Scientists are to assess the best course of treatment for various types of multiple sclerosis in a new trial.
Experts are launching a project comparing the effectiveness of stem cell transplants compared to the latest “disease-modifying treatments”.
Some patients involved in the trial will be given stem cell transplants if they have “highly active multiple sclerosis failing drug treatment” or as a first-line treatment for patients with the aggressive multiple sclerosis.
